Meeting of the National Advisory Committee on the National Health Service Corps, 1517-1518 [2021-00093]

Download as PDF 1517 Federal Register / Vol. 86, No. 5 / Friday, January 8, 2021 / Notices Application No. NDA 016801 Drug name Active ingredient(s) NDA 018238 XYLOCAINE PRELidocaine HydroSERVATIVE FREE. chloride. MICRO–K ................. Potassium Chloride .. NDA 019568 DERMATOP ............. Prednicarbate ........... NDA 020192 LAMISIL .................... NDA 020482 NDA 020591 PRECOSE ................ TARKA ...................... NDA 020635 LEVAQUIN ............... Terbinafine Hydrochloride. Acarbose .................. Trandolapril; Verapamil Hydrochloride. Levofloxacin .............. NDA 020823 EXELON ................... Rivastigmine Tartrate NDA 020920 NATRECOR ............. Nesiritide ................... NDA 021549 NDA 021590 EMEND ..................... FAZACLO ODT ........ Aprepitant ................. Clozapine .................. NDA 202535 PREPOPIK ............... Citric Acid, Magnesium Oxide, and Sodium Picosulfate. FDA has reviewed its records and, under § 314.161, has determined that the drug products listed were not withdrawn from sale for reasons of safety or effectiveness. Accordingly, the Agency will continue to list the drug products in the ‘‘Discontinued Drug Product List’’ section of the Orange Book. The ‘‘Discontinued Drug Product List’’ identifies, among other items, drug products that have been discontinued from marketing for reasons other than safety or effectiveness. Approved ANDAs that refer to the NDAs and ANDAs listed are unaffected by the discontinued marketing of the products subject to those NDAs and ANDAs. Additional ANDAs that refer to these products may also be approved by the Agency if they comply with relevant legal and regulatory requirements. If FDA determines that labeling for these drug products should be revised to meet current standards, the Agency will advise ANDA applicants to submit such labeling. Dated: January 4, 2021. Lauren K. Roth, Acting Principal Associate Commissioner for Policy. tkelley on DSKBCP9HB2PROD with NOTICES [FR Doc. 2021–00118 Filed 1–7–21; 8:45 am] BILLING CODE 4164–01–P VerDate Sep<11>2014 21:23 Jan 07, 2021 Jkt 253001 Strength(s) Dosage form/route Applicant 1%; 2%; 4%; 10%; 20% ............ Injectable; Injection ... 8 milliequivalents (mEq); 10 mEq. 0.10% ......................................... Extended-Release Capsule; Oral. Ointment; Topical ..... 1% .............................................. Cream; Topical ......... Fresenius Kabi USA, LLC. Nesher Pharmaceuticals LLC. Valeant Pharmaceuticals. Novartis. 25 mg; 50 mg; 100 mg .............. 1 mg; 240 mg ............................. Tablet; Oral ............... Extended-Release Tablet; Oral. Bayer Healthcare. AbbVie Inc. EQ 500 mg/20 mL; EQ 750 mg/ 30 mL. EQ 1.5 mg Base; EQ 3 mg Base; EQ 4.5 mg Base; EQ 6 mg Base. 1.5 mg/Vial ................................. Injectable; Injection ... Janssen Pharmaceuticals, Inc. Novartis. 40 mg ......................................... 12.5 mg; 25 mg; 100 mg; 150 mg; and 200 mg. 12 grams (g)/Packet; 3.5 g/ Packet; 10 mg/Packet. DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the National Advisory Committee on the National Health Service Corps Capsule; Oral ........... For Solution; Intravenous. Capsule; Oral ........... Orally Disintegrating Tablet; Oral. For Solution; Oral ..... Scios Inc. Merck. Jazz Pharmaceuticals PLC. Ferring Pharmaceuticals Inc. the meeting will be held, visit the NACNHSC website 30 business days before the date of the meeting, where instructions for joining meetings either in-person or remotely will also be posted. In-person NACNHSC meetings will be held at 5600 Fishers Lane, Rockville, Maryland 20857. For meeting information updates, go to the NACNHSC website meeting page at https://nhsc.hrsa.gov/nac/ meetings.html. Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. FOR FURTHER INFORMATION CONTACT: In accordance with the Federal Advisory Committee Act, this notice announces that the National Advisory Committee on the National Health Service Corps (NACNHSC) will hold public meetings for the 2021 calendar year (CY). Information about NACNHSC, agendas, and materials for these meetings can be found on the NACNHSC website at https:// nhsc.hrsa.gov/about/national-advisorycouncil-nhsc/. DATES: NACNHSC meetings will be held on • March 16, 2021, 9:00 a.m.–5:00 p.m. Eastern Time (ET) and March 17, 2021, 9:00 a.m.–2:00 p.m. ET; • June 22, 2021, 9:00 a.m.–5:00 p.m. ET and June 23, 2021, 9:00 a.m.–2:00 p.m. ET; • November 9, 2021, 9:00 a.m.–5: 00 p.m. ET and November 10, 2021, 9:00 a.m.–2:00 p.m. ET. ADDRESSES: Meetings may be held inperson, by teleconference, and/or Adobe Connect webinar. For updates on how Diane Fabiyi-King (DFO), Division of National Health Service Corps, Bureau of Health Workforce, HRSA, 5600 Fishers Lane, Rockville, Maryland 20857; 301–443–3609; or NHSCAdvisoryCouncil@hrsa.gov. SUPPLEMENTARY INFORMATION: NACNHSC provides advice and recommendations to the Secretary of HHS (Secretary) on policy, program development, and other matters of significance concerning the activities under Subpart II, Part D of Title III of the Public Health Service Act (42 U.S.C. 254d–254k). NACNHSC designates areas of the United States with health professional shortages and assigns National Health Service Corps clinicians to improve the delivery of health services in health professional shortage areas. Since priorities dictate meeting times and agenda items, be advised that start times, end times, and agenda items are subject to change. For CY 2021 meetings, agenda items may include, but are not limited to, the identification of NACNHSC priorities for future AGENCY: SUMMARY: PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\08JAN1.SGM 08JAN1 1518 Federal Register / Vol. 86, No. 5 / Friday, January 8, 2021 / Notices program issues and concerns; propose policy changes using the varying levels of expertise represented on the Council to advise on specific program areas; updates from clinician workforce experts; and education and practice improvement in the training development of primary care clinicians. More general items may include: Presentations and discussions on the current and emerging needs of health workforce; public health priorities; healthcare access and evaluation; NACNHSC-approved sites; HRSA priorities and other federal health workforce and education programs that impact the NACNHSC. Refer to the NACNHSC website listed above for all current and updated information concerning the CY 2021 NACNHSC meetings, including draft agendas and meeting materials that will be posted 30 calendar days before the meeting. Members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meeting(s). Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to the NACNHSC should be sent to Diane Fabiyi-King using the contact information above at least 5 business days before the meeting date(s). Individuals who need special assistance or another reasonable accommodation should notify Diane Fabiyi-King using the contact information listed above at least 10 business days before the meeting(s) they wish to attend. If a meeting is held in-person, it will occur in a federal government building and attendees must go through a security check to enter. Non-U.S. Citizen attendees must notify HRSA of their planned attendance at an in-person meeting at least 20 business days prior to the meeting in order to facilitate their entry into the building. All attendees are required to present government-issued identification prior to entry. tkelley on DSKBCP9HB2PROD with NOTICES Maria G. Button, Director, Executive Secretariat. [FR Doc. 2021–00093 Filed 1–7–21; 8:45 am] BILLING CODE 4165–15–P VerDate Sep<11>2014 21:23 Jan 07, 2021 Jkt 253001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the Council on Graduate Medical Education Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, this notice announces that the Council on Graduate Medical Education (COGME or Council) will hold public meetings for the 2021 calendar year (CY). Information about COGME, agendas, and materials for these meetings can be found on the COGME website at https:// www.hrsa.gov/advisory-committees/ graduate-medical-edu/. DATES: COGME meetings will be held on • April 14, 2021, 8:30 a.m.–5:00 p.m. Eastern Time (ET) and April 15, 2021, 8:30 a.m.–2:00 p.m. ET; • August 19, 2021, 10:00 a.m.–5:00 p.m. ET. ADDRESSES: Meetings may be held inperson, by teleconference, and/or Adobe Connect webinar. For updates on how the meeting will be held, visit the COGME website 30 business days before the date of the meeting where instructions for joining meetings either in-person or remotely will also be posted. In-person meetings will be held at 5600 Fishers Lane, Rockville, Maryland 20857. For meeting information updates, go to the COGME website meeting page at https:// www.hrsa.gov/advisory-committees/ graduate-medical-edu/meetings/ index.html. SUMMARY: FOR FURTHER INFORMATION CONTACT: Shane Rogers, Designated Federal Official, Division of Medicine and Dentistry, Bureau of Health Workforce, HRSA, 5600 Fishers Lane, Room 15N142, Rockville, Maryland 20857; 301–443–5260; or SRogers@hrsa.gov. SUPPLEMENTARY INFORMATION: COGME makes recommendations to the Secretary of HHS (Secretary) and Congress on policy, program development, and other matters of significance as specified by section 762 of Title VII of the Public Health Service (PHS) Act. Issues addressed by COGME include the supply and distribution of the physician workforce in the United States, including any projected shortages or excesses; foreign medical school graduates; the nature and financing of undergraduate and graduate PO 00000 Frm 00044 Fmt 4703 Sfmt 9990 medical education; appropriation levels for certain programs under Title VII of the PHS Act; and deficiencies in databases of the supply and distribution of the physician workforce and postgraduate programs for training physicians. COGME submits reports to the Secretary of HHS; the Senate Committee on Health, Education, Labor and Pensions; and the House of Representatives Committee on Energy and Commerce. Additionally, COGME encourages entities providing graduate medical education to conduct activities to voluntarily achieve the recommendations of the Council. Since priorities dictate meeting times, be advised that start times, end times, and agenda items are subject to change. For CY 2021 meetings, agenda items may include, but are not limited to, discussion on topics surrounding rural health workforce and training. Refer to the COGME website listed above for all current and updated information concerning the CY 2021 COGME meetings, including draft agendas and meeting materials that will be posted 30 calendar days before the meeting. Members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meeting(s). Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to COGME should be sent to Shane Rogers using the contact information above at least 5 business days before the meeting date(s). Individuals who need special assistance or another reasonable accommodation should notify Shane Rogers using the contact information listed above at least 10 business days before the meeting(s) they wish to attend. If a meeting is held in-person, it will occur in a federal government building and attendees must go through a security check to enter. Non-U.S. citizen attendees must notify HRSA of their planned attendance at an in-person meeting at least 20 business days prior to the meeting in order to facilitate their entry into the building. All attendees are required to present government-issued identification prior to entry. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2021–00058 Filed 1–7–21; 8:45 am] BILLING CODE 4165–15–P E:\FR\FM\08JAN1.SGM 08JAN1

Agencies

[Federal Register Volume 86, Number 5 (Friday, January 8, 2021)]
[Notices]
[Pages 1517-1518]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00093]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the National Advisory Committee on the National Health 
Service Corps

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the National Advisory Committee on the National 
Health Service Corps (NACNHSC) will hold public meetings for the 2021 
calendar year (CY). Information about NACNHSC, agendas, and materials 
for these meetings can be found on the NACNHSC website at https://nhsc.hrsa.gov/about/national-advisory-council-nhsc/.

DATES: NACNHSC meetings will be held on
     March 16, 2021, 9:00 a.m.-5:00 p.m. Eastern Time (ET) and 
March 17, 2021, 9:00 a.m.-2:00 p.m. ET;
     June 22, 2021, 9:00 a.m.-5:00 p.m. ET and June 23, 2021, 
9:00 a.m.-2:00 p.m. ET;
     November 9, 2021, 9:00 a.m.-5: 00 p.m. ET and November 10, 
2021, 9:00 a.m.-2:00 p.m. ET.

ADDRESSES: Meetings may be held in-person, by teleconference, and/or 
Adobe Connect webinar. For updates on how the meeting will be held, 
visit the NACNHSC website 30 business days before the date of the 
meeting, where instructions for joining meetings either in-person or 
remotely will also be posted. In-person NACNHSC meetings will be held 
at 5600 Fishers Lane, Rockville, Maryland 20857. For meeting 
information updates, go to the NACNHSC website meeting page at https://nhsc.hrsa.gov/nac/meetings.html.

FOR FURTHER INFORMATION CONTACT: Diane Fabiyi-King (DFO), Division of 
National Health Service Corps, Bureau of Health Workforce, HRSA, 5600 
Fishers Lane, Rockville, Maryland 20857; 301-443-3609; or 
[email protected].

SUPPLEMENTARY INFORMATION: NACNHSC provides advice and recommendations 
to the Secretary of HHS (Secretary) on policy, program development, and 
other matters of significance concerning the activities under Subpart 
II, Part D of Title III of the Public Health Service Act (42 U.S.C. 
254d-254k). NACNHSC designates areas of the United States with health 
professional shortages and assigns National Health Service Corps 
clinicians to improve the delivery of health services in health 
professional shortage areas. Since priorities dictate meeting times and 
agenda items, be advised that start times, end times, and agenda items 
are subject to change. For CY 2021 meetings, agenda items may include, 
but are not limited to, the identification of NACNHSC priorities for 
future

[[Page 1518]]

program issues and concerns; propose policy changes using the varying 
levels of expertise represented on the Council to advise on specific 
program areas; updates from clinician workforce experts; and education 
and practice improvement in the training development of primary care 
clinicians. More general items may include: Presentations and 
discussions on the current and emerging needs of health workforce; 
public health priorities; healthcare access and evaluation; NACNHSC-
approved sites; HRSA priorities and other federal health workforce and 
education programs that impact the NACNHSC.
    Refer to the NACNHSC website listed above for all current and 
updated information concerning the CY 2021 NACNHSC meetings, including 
draft agendas and meeting materials that will be posted 30 calendar 
days before the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting(s). Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to the NACNHSC should 
be sent to Diane Fabiyi-King using the contact information above at 
least 5 business days before the meeting date(s).
    Individuals who need special assistance or another reasonable 
accommodation should notify Diane Fabiyi-King using the contact 
information listed above at least 10 business days before the 
meeting(s) they wish to attend.
    If a meeting is held in-person, it will occur in a federal 
government building and attendees must go through a security check to 
enter. Non-U.S. Citizen attendees must notify HRSA of their planned 
attendance at an in-person meeting at least 20 business days prior to 
the meeting in order to facilitate their entry into the building. All 
attendees are required to present government-issued identification 
prior to entry.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021-00093 Filed 1-7-21; 8:45 am]
BILLING CODE 4165-15-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.